PARP1 and chronic myelogenous leukemia, BCR-ABL1 positive: In all CML cell lines, we observed a strong induction of PARP1 cleavage when combining imatinib with oligomycin, thapsigargin, or 8-Cl-Ado, compared to imatinib only (Fig. 4c).